Perihan ÜNAK, Uğur AVCIBAŞI, Yasemin PARLAK, Volkan TEKİN, Hasan DEMİROĞLU, Gökçen TOPAL, Fikriye Gül GÜMÜŞER, Elgin ULUER TÜRKÖZ, Buket ATEŞ

99mTc-Trimethoprim’in Radyosentezi ve Biyodağılımı: Deney Hayvanları Kullanılarak Bakteriyel Enfeksiyon Görüntüleme İçin Yeni Bir Radyoişaretli Antibiyotik

Bu çalışmada in vivo enfeksiyon görüntüleme için potansiyel bir aday olarak 99mTc-TMH’ı değerlendirdik ve radyosentezi üzerine odaklandık. Bunun için bakterilerden kaynaklı enfeksiyonların tedavisinde kullanılan Trimethoprim (TMH) 99mTc ile işaretlenmiştir. İşaretlenme oda sıcaklığında 1 saat süreyle bir indirgenme ajanı olan Sn(II)Cl2 kullanılarak gerçekleştirilmiş ve ince tabaka radyokromatografi (TLRC) ve yüksek basınçlı sıvı radyokromatografisi (HPLRC) metodlarını içeren radyokimyasal analizler yapılmıştır. İşaretli antibiyotiğin sıçan kan serumundaki kararlılığı 37ºC’de 180. dk.’ya kadar kontrol edilmiştir. Maksimum bağlanma verimi %96±2 olarak bulunmuş ve işaretli antibiyotiğin işaretlenmeden sonra 180 dk süresi içinde sıçan serumunda %85±1’in üzerindeki bir oranda sabit kaldığı görülmüştür. Dişi sıçanlardaki 99mTcTMH’ın statik görüntüsü ilk 30 dk içinde enfeksiyon bölgesinde işaretli antibiyotiğin önemli bir radyasyon sinyali verdiğini göstermiştir. 30 dk sonra 99mTc-TMH’ın enfekte kas (INM) ve normal kas (NM) daki tutulum değerleri sırasıyla %7.5±1.5 ve %5.00±1.2 dir. INM/NM oranı 10.6 değerine kadar attığı için INM/NM oranında makul bir artış gözlenmiştir. Yüksek verimle hazırlanmış 99mTc-TMH bakteriler tarfından enfekte edilmiş sıçan kaslarında lokalize olabilmektedir. Sonuç olarak 99mTc-TMH nükleer görüntülemede kullanılabilecek bir radyofarmasötik olarak geliştirilebilir.

Radiosynthesis and Biodistribution of 99mTc-Trimethoprim: A Novel Radiolabeled Antibiotic for Bacterial Infection Imaging Using Experimental Animals

In the present article, we focused on the radiolabeling and evaluation of 99mTc–TMH complex as a potential candidate for infection imagingin vivo. For this; Trimethoprim (TMH) used to treat bacterial infections was investigated to label with 99mTc. Labeling was performed usingthin (II) chloride as a reducing agent at room temperature for 1 h and radiochemical analysis involved thin layer radiochromatography (TLRC)and high pressure liquid radiochromatograpy (HPLRC) methods. The stability of labeled antibiotic was checked in the presence of rat bloodserum at 37ºC up to 180 min. The maximum radiolabeling yield was found to be 96±2% and remained constant at more than 85±1% even inrat serum for 180 min after radiolabeling. Static image of 99mTc-TMH in male rats demonstrated that important radiation signals are present inthe infected site at first glance in 30 min. After 30 min the uptake of the 99mTc-TMH as ID/g% in the infected muscle (INM) and normal muscle(NM) of the rats were 7.5±1.5% and 5.00±1.2%, respectively. In the INM/NM ratio a desirable behavior was observed as the values for the INM/NM increased up to 10.6. 99mTc-TMH prepared with high yield is able to localize well in the bacterially infected muscle of the rats. As a result, 99mTc-TMH may be developed as a radiopharmaceutical agent to distinguish infection from inflammation by nuclear imaging.

PDF

___

Ertay T, Ünak P, Eren MŞ, Müftüler FZB, Özdoğan Ö, Ülker Ö, Yeşilağaç R, Durak H: A New 99mTc labeled peptide: 99mTc β-casomorphin 6, biodistribution and imaging studies on rats. Kafkas Univ Vet Fak Derg, 23 (1): 15-22, 2017. DOI: 10.9775/kvfd.2016.15691
Liberatore M, Fiore V, D’Agostini A, Prosperi D, Iurilli AP, Santini C, Baiocchi P, Galiè M, Di Nucci GD, Sinatra R: Sternal wound infection revisited. Eur J Nucl Med, 27, 660-667, 2000. DOI: 10.1007%2Fs002590050560
Diniz SO, Rezende CM, Serakides R, Ferreira RL, Ribeiro TG, Martin-Comin J, Cardoso VN: Scintigraphic imaging using technetium99m-labeled ceftizoxime in an experimental model of acute osteomyelitis in rats. Nucl Med Commun, 29, 830-836, 2008. DOI: 10.1097/ MNM.0b013e3283000514
Palestro CJ, Love C, Tronco GG, Tomas MB: Role of radionuclide imaging in the diagnosis of postoperative infection. Radiographics, 20, 1649-1660, 2000. DOI: 10.1148/radiographics.20.6.g00nv101649
Li CH, Chen Y, Zhang CH, Dong Z, Wang Z, Zhao SN, Wang YX, LV ZY, Zhang PL: Observation of clinical efficacy of rt-PA intravenous thrombolytic treatment for patients combined with grade 0-1 diabetic foot by Wagner classification and acute ischemic stroke. Eur Rev Med Pharmacol Sci, 20, 5168-5173, 2016.
Uyaroğlu Ö, Demiroğlu H, Topal G, Parlak Y, Gümüşer FG, Türköz EU, Tekin V, Ateş B, Ünak P, Avcıbaşı U: Radiosynthesis and biodistribution of 99mTc- Sulfamethoxazole: A novel molecule for in-vivo infection imaging. Med Chem, 26, 3149-3157, 2017. DOI: 10.1007/s00044- 017-2009-4
Özdemir Dİ, Asikoglu M, Ozkilic H, Yılmaz F, Limoncu MH, Ayhan S: 99mTc-doxycycline hyclate: A new radiolabeled antibiotic for bacterial infection imaging. J Label Compd Radiopharm, 2013 DOI: 10.1002/jlcr.3135
Shah SQ, Khan MR: Synthesis of techentium-99 m labeled clinafloxacin (99mTc-CNN) complex and biological evaluation as a potential Staphylococcus aureus infection imaging agent. J Radioanal Nucl Chem, 288, 423-428, 2011.
Shah SQ, Khan MR: Radiosynthesis and characterization of the 99mTc-fleroxacin (99mTc-FXN) complex: A novel Escherichia coli infection imaging agent. Transit Met Chem, 36, 283-288, 2011.
Shah SQ, Khan MR: (99m)Tc-prulifloxacin in artificially infected animals: Radiosynthesis and biological evaluation of 99mTc-prulifloxacin in artificially infected animals. Nuklearmedizin, 50, 134-140, 2011. doi: 10.3413/Nukmed-0334-10-07
Shah SQ, Khan MR: Synthesis of the 99mTc(CO)3- trovafloxacin dithiocarbamate complex and biological evaluation in artificially methicillin-resistant Staphylococcus aureus infected rats model. J Radioanal Nucl Chem, 288, 297-302, 2011. DOI: 10.1007/s10967-010- 0914-9
Shah SQ, Khan MR: 99mTc(CO)3-tosufloxacin dithiocarbamate complexation and radiobiological evaluation in male Wister rat model. J Radioanal Nucl Chem, 288, 485-490, 2011. DOI: 10.1007/s10967- 010-0943-4
Shah SQ, Khan AU, Khan MR: Radiosynthesis, biodistribution and scintigraphy of the 99mTc-teicoplanin complex in artificially infected animal models. J Label Compd Radiopharm, 54, 145-152, 2010. DOI: 10.1002/jlcr.1834
Shah SQ, Khan AU, Khan MR: 99mTc-novobiocin: A novel radiotracer for infection imaging. Radiochimica Acta, 99, 53-58, 2011. DOI: 10.1524/ ract.2011.1790
Shah SQ, Khan AU, Khan MR: Radiosynthesis and biodistribution of 99mTc-rifampicin: A novel radiotracer for in-vivo infection imaging. Appl Radiat Isot, 68, 2255-2261, 2010. DOI: 10.1016/j.apradiso.2010.05.014
Burke SL, Rose WE: New pharmacological treatments for methicillinresistant Staphylococcus aureus infections. Expert Opin Pharmacother, 15 (4): 483-491, 2014. DOI: 10.1517/14656566.2014.876991
Stumpe KDM, Dazzi H, Schaffner A, Von Schulthess GK: Infection imaging using whole-body FDG-PET. Eur J Nucl Med, 27, 822-826, 2000. DOI: 10.1007/s002590000277
Gallagher H, Ramsay SC, Barnes J, Maggs J, Cassidy N, Katheesan: Neutrophil labeling with [99mTc]-technetium stannous colloid is complement receptor 3-mediated and increases the neutrophil priming response to lipopolysaccharide. Nucl Med Biol, 33, 433-437, 2006. DOI: 10.1016/j.nucmedbio.2005.12.014
Szczepanowski R, Linke B, Krahn I, Gartemann KH, Gützkow T, Eicher W, Pühler A, Schlüter A: Detection of 140 clinically relevant antibiotic-resistance genes in the plasmid metagenome of waste water treatment plant bacteria showing reduced susceptibility to selected antibiotics. Microbiology, 155, 2306-2319, 2009. DOI: 10.1099/ mic.0.028233-0
Xu J, Xu Y, Wang H, Gua C, Qiu H, He Y, Zhang Y, Li X, Meng W: Occurrence of antibiotics and antibiotic resistance genes in a sewage treatment plant and its effluent-receiving river. Chemosphere, 119, 1379- 1385, 2015. DOI: 10.1016/j.chemosphere.2014.02.040
Phuong Hoa PT, Nonaka L, Hung VP, Suziki S: Detection of the sul1, sul2, and sul3 genes in sulfonamide-resistant bacteria from waste water and shrimp ponds of north Vietnam. Sci Total Environ, 405, 377-384, 2008. DOI: 10.1016/j.scitotenv.2008.06.023
Chang H, Hu J, Asami M, Kunikane S: Simultaneous analysis of 16sulfonamide and trimethoprim antibiotics in environmental waters by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A, 1190, 390-393, 2008. DOI: 10.1016/j.chroma.2008.03.057
Gobel A, Thomsen A, McArdell CS, Joss A, Giger W: Occurrence andsorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ Sci Technol, 39, 3981-3989, 2005. DOI: 10.1021/es048550a
Gobel A, McArdell CS, Suter MJF, Giger W: Trace determination of macrolide and sulfonamide antimicrobials, a human sulfonamide metabolite, and trimethoprim in waste water using liquid chromatography coupled toelectrospray tandem mass spectrometry. Anal Chem, 76, 4756- 4764, 2004. DOI: 10.1021/ac0496603
De Paula FC, De Pietro AC, Cass QB: Simultaneous quantification of sulfamethoxazole and trimethoprim in whole egg samples by columnswitching high-performance liquid chromatography using restricted access media column for on-line sample clean-up. J Chromatogr A, 1189, 221-226, 2008. DOI: 10.1016/j.chroma.2007.08.046
Nieto A, Borrull F, Marce RM, Pocurull E: Selective extraction of sulfonamides, macrolides and other pharmaceuticals from sewage sludge bypressurized liquid extraction. J Chromatogr A, 1174, 125-131, 2007. DOI: 10.1016/j.chroma.2007.09.068
Baquero F, Martínez JL, Cantón R: Antibiotics and antibiotic resistance inwater environments. Curr Opin Biotechnol, 19, 260-265, 2008. DOI: 10.1016/ j.copbio.2008.05.006
Ferk, F, Misik M, Grummt T, Majer B, Fuerhacker M, Buchmann C, Vital M, Uhl M, Lenz K, Grillitsch B, Parzefall W, Nersesyan A, Knasmuller S: Genotoxic effects of wastewater from an oncological ward. Mutat Res-Gen Tox En, 672 (2): 69-75, 2009. DOI: 10.1016/j.mrgentox. 2008.08.022
Correa A, del Campo R, Escandon-Vargas K, Perenguez M, Rodriguez-Banos M, Hernandez-Gomez C, Pallares C, Perez F, Arias CA, Canton R, Villegas MV: Distinct genetic diversity of carbapenemresistant Acinetobacter baumannii from Colombian Hospitals. Microb Drug Resist, 24 (1): 48-54, 2018. DOI: 10.1089/mdr.2016.0190
Kaur A, Khan IA, Banipal PK, Banipal TS: Deciphering the complexation process of a fluoroquinole antibiotic, levofloxacin, with bovine serum albumin in the presence of additives. Spectrochim Acta A Mol Biomol Spectrosc, 191, 259-270, 2018. DOI: 10.1016/j.saa.2017.10.017
Sefton AM: Mechanisms of antimicrobial resistance-their clinical relevance in the new millennium. Drugs, 62, 557-566, 2002.
Levy SB, Marshall B: Antibacterial resistance worldwide: Causes, challenges and responses. Nat Med, 10, S122-S129, 2004. DOI: 10.1038/ nm1145
Elbashir S, Parveen S, Schwarz J, Rippen T, Jahncke M, DePaola A: Seafood pathogens and information on antimicrobial resistance: A review. Food Microbiol, 70, 8593, 2018. DOI: 10.1016/j.fm.2017.09.011